Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism) will be divided to groups (twenty female for the group). groups will be treated with levothyroxine and metformin, but one of these groups will perform aerobic treadmill walking.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group number 1 | Experimental | twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin, and these females will perform 50 minutes of aerobic treadmill walking hrice weekly for six month. |
|
| group number 2 | Active Comparator | twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin for six month |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| physical exercise program | Behavioral | twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin, and these females will perform 50 minutes of aerobic treadmill walking hrice weekly for six month. |
| Measure | Description | Time Frame |
|---|---|---|
| Dehydroepiandrosterone | it is a hormone involved in synthesis of sex hormones | it will be measured after 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| ratio of leutinzing hromone to hormone of follicels stimulatting hormones | this ration express level of sex hormone | it will be measured after 6 months |
| testesterone | it is a sex horomone |
Not provided
Inclusion Criteria:
Exclusion Criteria:
based on self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali MA Ismail, lecturer | Contact | 01005154209 | ali.mohamed@pt.cu.edu.eg | |
| ali mohamed | Contact | 01031321109 | allooka2012@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali MA Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo Unoversity | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D011085 | Polycystic Ovary Syndrome |
| ID | Term |
|---|---|
| D010048 | Ovarian Cysts |
| D003560 | Cysts |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| usual care | Other | twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily two times of 500-mg metformin for six month. |
|
| it will be measured after 6 months |
| body mass index | it will be assessed on empty stomach and bladder | it will be measured after 6 months |
| waist circumference | it will be assessed on umblical levels | it will be measured after 6 months |
| blood gluocose | it will be assessed in fasting status | it will be measured after 6 months |
| glycated hemoglubin | it is an indiactor for longterm satus of blood gloucose | it will be measured after 6 months |
| insulin | it will be assessed in plasma | it will be measured after 6 months |
| thyroid stimualtined horomone | it will be assessed in plasma | it will be measured after 6 months |
| triglyceridess | it will be assessed in plasma | it will be measured after 6 months |
| low densitiy liopporotein | it will be assessed in plasma | it will be measured after 6 months |
| cholesteroll | it will be assessed in plasma | it will be measured after 6 months |
| high densitiy lipoporteins | it will be assessed in plasma | it will be measured after 6 months |
| alanine transaminase | it will be assessed in plasma | it will be measured after 6 months |
| aspartatte transaminase | it will be assessed in plasma | it will be measured after 6 months |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |